Integrated Animal Health Expands Global Presence with New Zealand and EU Office and Personnel Announcements. The company also appoints Domhealth as New Zealand distributor

LAWRENCE, Kan., Sept. 16, 2015 – Integrated Animal Health (IAH), LLC, a global company focused on identifying and commercializing new-to-the-world animal health solutions, is expanding its global footprint with offices in Budapest, Hungary and Auckland, New Zealand.
Charged with heading up these new offices are Laszlo Kiss, D.V.M., M.B.A., Integrated Animal Health European director, and Jo Wrigley, Integrated Animal Health New Zealand business development manager.
As head of the European office, Dr. Kiss will oversee business development, as well as distributor and licensing agreements in EU and non-EU countries in Europe. With more than 15 years of experience in both established and start-up environments, Dr. Kiss is a versatile animal health business executive with experience across Europe, the United States and the Middle East. He possesses broad experience in the animal health and nutrition sectors launching new products, managing cross-cultural selling teams, creating effective distribution, licensing and sales strategies and delivering excellent customer service.
Dr. Kiss obtained his doctorate of veterinary medicine from the University of Veterinarian Sciences, Budapest, and his masters of business administration from Central European University, Budapest.
Jo Wrigley comes to Integrated Animal Health with more than 20 years in the animal health industry. Firmly entrenched in the New Zealand agricultural and animal health industry, she has a strong background in R&D, as well as sales and marketing, and has published numerous industry articles. Wrigley has been a dairy farm consultant, run clinical trials for Merial Ancare in New Zealand and Australia, served a stint with Elanco in central Queensland, and most recently served as the managing director of an animal health distribution company. Wrigley has an animal science degree from Massey University with a focus in ruminant nutrition.
Wrigley will oversee the New Zealand office, and lead all business development efforts, licensing and distribution arrangements in New Zealand, including the recent appointment of IAH's newest distributor, Domhealth.
Both Kiss and Wrigley will focus in the near term on expanding IAH's core commercial technologies, including Udder-Mate™, also known as Feed-Mate™ in the UK and Ireland, Scour-Mate™ and its new feed technology that naturally repels flies for the beef and dairy industries, as well as its suite of Equine-Max® performance supplements for horses.
"To fulfill our mission to be the new innovation engine for animal health, we will hire only the most exceptional people," says Blake Hawley, D.V.M., M.B.A., Integrated Animal Health president and chief executive officer. "Dr. Kiss and Ms. Wrigley exemplify the expertise, leadership and passion we need to implement the IAH business strategy in these markets, and achieve our licensing, sales and knowledge transfer goals."
Domhealth secured as New Zealand distributor
IAH will begin exclusive distribution of its core product technologies in New Zealand through Domhealth, a New Zealand owned and operated animal health company that has been providing innovative animal health solutions through products and technical support for 25 years. The company develops and manufactures animal health products that are distributed nationwide. Domhealth products are endorsed and trusted by farmers, veterinarians, top equestrian riders, as well as horse racing trainers and breeders.
"Domhealth is focused on finding the right solution for a particular farm, and working collaboratively with veterinarians and other industry professionals to achieve the best outcomes," says Wrigley. "They have some unique formulations and in many ways share the same philosophy for innovation as IAH, making it a natural partnership."
About Integrated Animal Health
Integrated Animal Health (IAH) provides multiple pathways to market for products that aim to disrupt current paradigms for the use of antibiotics, pesticides and novel animal drugs, biologics and cancer therapies used in animals. With world headquarters in the heart of the Animal Health Corridor, IAH is the new engine that is driving innovation in animal health by helping companies bring transformative solutions to market. Its technologies target significant and costly issues in production animal systems, such as mastitis, scours and fly control to help companies satisfy consumer demand for sustainable, natural and antibiotic-free products while meeting the demand for growth. Offering a deep and fertile pipeline of more than 30 pioneering technology platforms, IAH is advancing its pipeline to include a wide range of applications, including products targeting equine and companion animal markets. The company has offices at the Bioscience and Technology Business Center in Lawrence, Kan., as well as in Australia, Europe and New Zealand. For more information, visit the new re-launched website at iahglobal.com.
###
Media Contact: Susan Wright, 1-913-213-6819, [email protected]

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…